Enzymotec To Participate In The 16th Annual ICR Xchange Conference
1/7/2014 9:47:14 AM
MIGDAL HA'EMEQ, Israel, Jan. 6, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec"), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, announced today that Dr. Ariel Katz, President and Chief Executive Officer, and Oren Bryan, Chief Financial Officer, will present at the 16th Annual ICR XChange Conference on Monday, January 13, 2014 at 10:00 a.m. ET in Orlando, FL.
Help employers find you! Check out all the jobs and post your resume.
comments powered by